Imbruvica (ibrutinib)

pCPA File Number: 22541
Negotiation Status:
Active Negotiation
Indication(s):
Waldenström's Macroglobulinemia
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
PC0328-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable